BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1926066)

  • 1. Antithrombin activity of a fucan sulfate from the brown seaweed Ecklonia kurome.
    Nishino T; Aizu Y; Nagumo T
    Thromb Res; 1991 Jun; 62(6):765-73. PubMed ID: 1926066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of sulfate content and molecular weight of a fucan sulfate from the brown seaweed Ecklonia kurome on its antithrombin activity.
    Nishino T; Aizu Y; Nagumo T
    Thromb Res; 1991 Dec; 64(6):723-31. PubMed ID: 1798961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the generation of thrombin and factor Xa by a fucoidan from the brown seaweed Ecklonia kurome.
    Nishino T; Fukuda A; Nagumo T; Fujihara M; Kaji E
    Thromb Res; 1999 Oct; 96(1):37-49. PubMed ID: 10554083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation, purification, and characterization of fucose-containing sulfated polysaccharides from the brown seaweed Ecklonia kurome and their blood-anticoagulant activities.
    Nishino T; Yokoyama G; Dobashi K; Fujihara M; Nagumo T
    Carbohydr Res; 1989 Feb; 186(1):119-29. PubMed ID: 2720702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulant and antithrombin activities of oversulfated fucans.
    Nishino T; Nagumo T
    Carbohydr Res; 1992 May; 229(2):355-62. PubMed ID: 1394292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective activation of heparin cofactor II by a sulfated polysaccharide isolated from the leaves of Artemisia princeps.
    Hayakawa Y; Hayashi T; Hayashi T; Niiya K; Sakuragawa N
    Blood Coagul Fibrinolysis; 1995 Oct; 6(7):643-9. PubMed ID: 8562835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of potentiation of antithrombin III and heparin cofactor II inhibition by sulfated xylans.
    Carson L; Doctor VM
    Thromb Res; 1990 May; 58(4):367-81. PubMed ID: 1972302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticoagulant properties of a fucoïdan fraction.
    Colliec S; Fischer AM; Tapon-Bretaudiere J; Boisson C; Durand P; Jozefonvicz J
    Thromb Res; 1991 Oct; 64(2):143-54. PubMed ID: 1811335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombin activity of fucoidan. The interaction of fucoidan with heparin cofactor II, antithrombin III, and thrombin.
    Church FC; Meade JB; Treanor RE; Whinna HC
    J Biol Chem; 1989 Feb; 264(6):3618-23. PubMed ID: 2914965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different glycoforms of human thrombomodulin. Their glycosaminoglycan-dependent modulatory effects on thrombin inactivation by heparin cofactor II and antithrombin III.
    Koyama T; Parkinson JF; Sié P; Bang NU; Müller-Berghaus G; Preissner KT
    Eur J Biochem; 1991 Jun; 198(3):563-70. PubMed ID: 1646716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Respective role of antithrombin III and heparin cofactor II in the in vitro anticoagulant effect of heparin and of various sulphated polysaccharides.
    Sie P; Ofosu F; Fernandez F; Buchanan MR; Petitou M; Boneu B
    Br J Haematol; 1986 Dec; 64(4):707-14. PubMed ID: 2432917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombin-III assay without influence of heparin cofactor II.
    Enomoto M; Tanimizu I; Sakuragawa N
    Thromb Res; 1990 Mar; 57(5):729-36. PubMed ID: 2339367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of thrombin by antithrombin III and heparin cofactor II in vivo.
    Liu L; Dewar L; Song Y; Kulczycky M; Blajchman MA; Fenton JW; Andrew M; Delorme M; Ginsberg J; Preissner KT
    Thromb Haemost; 1995 Mar; 73(3):405-12. PubMed ID: 7545318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of the sulfated lactobionic acid amide LW 10082 with thrombin and its endogenous inhibitors.
    Klauser RJ
    Thromb Res; 1991 Jun; 62(5):557-65. PubMed ID: 1896968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-thrombin activities of heparin. Effect of saccharide chain length on thrombin inhibition by heparin cofactor II and by antithrombin.
    Bray B; Lane DA; Freyssinet JM; Pejler G; Lindahl U
    Biochem J; 1989 Aug; 262(1):225-32. PubMed ID: 2818566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrin moderates the catalytic action of heparin but not that of dermatan sulfate on thrombin inhibition in human plasma.
    Okwusidi JI; Anvari N; Kulczycky M; Blajchman MA; Buchanan MR; Ofosu FA
    J Lab Clin Med; 1991 May; 117(5):359-64. PubMed ID: 2019790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin cofactor II-dependent antithrombin activity of calcium spirulan.
    Hayakawa Y; Hayashi T; Hayashi K; Hayashi T; Ozawa T; Niiya K; Sakuragawa N
    Blood Coagul Fibrinolysis; 1996 Jul; 7(5):554-60. PubMed ID: 8874866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative studies of heparin cofactor activity toward antithrombin III and heparin cofactor II, and antithrombin III affinity between low molecular weight heparin and unfractionated heparin.
    Shimotori T; Sakuragawa N
    Semin Thromb Hemost; 1990 Oct; 16 Suppl():71-6. PubMed ID: 1962909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The antithrombin action of stichopus japonicus acid mucopolysaccharide (Sjamp) is mediated by heparin cofactor II].
    Zhang G
    Zhonghua Xue Ye Xue Za Zhi; 1997 Mar; 18(3):126-9. PubMed ID: 15622771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The sulfate-content dependence of the anticoagulant activity of a fucan sulfate from the brown seaweed Ecklonia kurome.
    Nishino T; Nagumo T
    Carbohydr Res; 1991 Jul; 214(1):193-7. PubMed ID: 1954631
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.